Corporations like funding In the front, but first what the heck does that mean? To fund the acquisition of Kite Pharma, Gilead Sciences priced a $3 billion bond deal and took out a $6 billion term loan. This in itself isn’t that unusual. Companies have been making heavy use of low-interest rates to finance acquisitions through debt since the great financial crisis. [klarman] Imagine A World Without Cash S&P 500 Corporate Cash At $1.7 Trillion As Firms Gorge On Debt How Will Berkshire Hathaway Deploy Its $100 Billion in Cash … However, what’s interesting to note about this deal according to Bank…
Companies Favor Funding In The Front End As Repatriation Looms
Sign up now and get our in-depth FREE e-books on famous investors like Klarman, Dalio, Schloss, Munger Rupert is a committed value investor and regularly writes and invests following the principles set out by Benjamin Graham. He is the editor and co-owner of Hidden Value Stocks, a quarterly investment newsletter aimed at institutional investors. Rupert owns shares in Berkshire Hathaway. Rupert holds qualifications from the Chartered Institute For Securities & Investment and the CFA Society of the UK. Rupert covers everything value investing for ValueWalk